Project Grant T32AI170501

Award Date 7/1/24
Completion Date 6/30/29
Dollars Obligated $373K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $266,615 to the University of Rochester to train the next generation of physician-scientists in conducting cutting-edge research on autoimmune, allergic, and infectious diseases. The key objectives are to: 1) recruit and provide rigorous research training to a diverse pool of resident physicians in internal medicine,...
This federal Project Grant award of $179,475 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports a research project titled "TARGETING IMMUNE DYSREGULATED ENDOTYPES IN SEPSIS (TIDES)" at The Children's Hospital of Philadelphia (CHOP). The objectives of this 3-year project are to: 1) Define and prospectively evaluate a model to identify prognostic molecular sepsis subphenotypes, and 2) Determine the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $195,894.00 to The Washington University to study the mechanisms contributing to T cell dysregulation in STAT3 gain-of-function (GOF) syndrome. The primary scientific goal is to investigate critical interactions between T and B cells, as well as the development, polarization, and function of these cells, in order to...
This Project Grant award in the amount of $402,731 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to increase the number of physician-scientists focused on reproductive, maternal, and child health. The award will support four physician-scientists in pediatrics or obstetrics/gynecology residency to complete one year of laboratory-based training in immunology or infectious diseases. The program...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to investigate the immune mechanisms underlying immune-related adverse events (IRAEs) that can occur following checkpoint inhibitor cancer immunotherapy. The $906,930 award will fund a prospective cohort study to characterize the phenotype and antigen-specificity of the autoreactive CD4+ T cells involved...
This federal Project Grant award of $2,651,713 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program will establish the Philadelphia Program for Mentored Research Training in Kidney, Urologic, and Hematologic Diseases (PERFORM-KUH). The program aims to develop skilled investigators trained to conduct impactful research in clinical, translational, or basic science related to...
This Project Grant award, valued at $194,740, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding supports research to characterize the development of lung-resident, self-antigen-specific regulatory T cells (Tregs) following acute lung injury, with the goal of understanding how these "experienced" Tregs can promote tolerance and prevent future lung disease. The...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $142,599 to the University of Texas at San Antonio (UTSA) to recruit, train, and graduate a diverse group of doctoral students in the multidisciplinary areas of molecular microbiology and immunology. The program aims to provide interdisciplinary training across host-pathogen interactions, immunology, genomics, and...
This federal Project Grant award of $534,000.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate how antigen location and peptide-MHC class II (pMHCII) complex density and half-life can drive CD4+ T cell differentiation and functionality. The research, conducted by the Children's Hospital of Philadelphia (CHOP), aims to test a model proposing that extracellular...
This Project Grant award of $196,992 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a 5-year research and career development plan for Dr. Gloria Yiu at the University of California, Los Angeles (UCLA). The key objectives are to: Enhance endogenous FOXP3 expression in induced pluripotent stem cells (iPSCs) and compare the immunophenotype, transcriptional pattern, epigenetic profile, and...

PHYSICIAN SCIENTIST TRAINING PROGRAM IN IMMUNE DYSREGULATION - PROJECT SUMMARY THIS NEW T32 TRAINING PROGRAM IN IMMUNE DYSREGULATION IS DESIGNED TO SUCCESSFULLY TRAIN THE NEXT GENERATION OF PHYSICIAN-SCIENTISTS, WORKING AT THE INTERFACE OF NORMAL AND PATHOLOGIC IMMUNE FUNCTION WITH END ORGAN DAMAGE TO ELUCIDATE THE ROOT CAUSES OF IMMUNE DYSREGULATION SYNDROMES AND TO DEVELOP NOVEL APPROACHES TOWARDS THEIR DIAGNOSIS, MONITORING, AND TREATMENT. THE PROGRAM REQUESTS THE SUPPORT OF 4 PHYSICIAN-SCIENTIST POSTDOCTORAL TRAINEES, WHO ARE COMPETITIVELY SELECTED FROM VARIOUS CLINICAL FELLOWSHIP PROGRAMS AT THE HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA (PENN) AND THE CHILDREN'S HOSPITAL OF PHILADELPHIA (CHOP). SELECTION CRITERIA INCLUDE HIGH STANDARDS OF COMPETENCE, MOTIVATION AND PERSEVERANCE, AND A STRONG COMMITMENT TO A RESEARCH CAREER IN IMMUNOBIOLOGY. RECRUITMENT OF QUALIFIED, DIVERSITY TRAINEES THAT INCLUDES URM IS HIGH PRIORITY. THIS PROGRAM UNIQUELY PROVIDES TRAINING IN BOTH ADULT AND CHILDHOOD IMMUNE DISEASES AS IT SITS AT THE NEXUS OF PENN AND CHOP AND TAKES ADVANTAGE OF THE INSTITUTE FOR IMMUNOLOGY, SPECIALIZED CENTERS IN AUTOIMMUNITY, AND THE FRONTIER PROGRAM IN IMMUNE DYSREGULATION TO OFFER MULTI-DISCIPLINARY TRAINING IN BOTH BASIC AND TRANSLATIONAL RESEARCH RELATED TO IMMUNE DYSREGULATION. THE PROGRAM WILL BE DIRECTED BY 3 PHYSICIAN SCIENTISTS (DRS. TAKU KAMBAYASHI, EDWARD BEHRENS, AND WARREN PEAR). DR. KAMBAYASHI WILL BE RESPONSIBLE FOR TRAINEES AT PENN. DR. KAMBAYASHI IS A PHYSICIAN SCIENTIST IN TRANSFUSION MEDICINE AND SERVES AS A PROGRAM ADVISOR FOR THE MSTP PROGRAM, THE CHAIR OF THE IMMUNOLOGY GRADUATE GROUP, AND THE DIRECTOR OF THE PHYSICIAN SCIENTIST PROGRAM FOR PATHOLOGY RESIDENCY. DR. BEHRENS WILL BE RESPONSIBLE FOR TRAINEES AT CHOP. DR. BEHRENS IS A PHYSICIAN SCIENTIST IN RHEUMATOLOGY AND SERVES AS THE CHIEF OF PEDIATRIC RHEUMATOLOGY AT CHOP. DR. PEAR WILL PROVIDE GENERAL PROGRAM OVERSIGHT AS THE MOST SENIOR MEMBER OF THE CO-PROGRAM DIRECTORS. HE IS A PHYSICIAN SCIENTIST IN MOLECULAR PATHOLOGY AND SERVES AS THE DEPUTY DIRECTOR OF THE IFI, VICE CHAIR OF RESEARCH FOR THE DEPARTMENT OF PATHOLOGY, AND CO-LEADER OF THE IMMUNOLOGY PROGRAM IN THE ABRAMSON CANCER INSTITUTE. ALL CO- PROGRAM DIRECTORS RUN A SUCCESSFUL NIH-FUNDED LAB IN BASIC AND TRANSLATIONAL IMMUNOLOGY. THE PROGRAM WILL ALSO CONSIST OF AN ADMINISTRATIVE STRUCTURE THAT OVERSEES THE NEEDS AND IMPROVEMENT OF THE TRAINING PROGRAM, ASSISTED BY AN EXECUTIVE COMMITTEE, INTERNAL ADVISORY BOARD, AND AN EXTERNAL ADVISORY BOARD. THERE ARE 25 FACULTY TRAINERS TO MATCH THE 4 REQUESTED POSTDOCTORAL SLOTS. DIVERSE AREAS OF RESEARCH IN IMMUNE DYSREGULATION ARE REPRESENTED AMONGST OUR PARTICIPATING FACULTY TRAINERS, RANGING FROM IMMUNITY AGAINST INFECTION, AUTOIMMUNITY, MOLECULAR AND CELLULAR IMMUNOLOGY IN VARIOUS ORGAN SYSTEMS. EACH FACULTY TRAINER (EXCEPT FOR THE 3 JUNIOR TRAINERS) HAS EXTENSIVE EXPERIENCE IN MENTORING POST-DOCTORAL FELLOWS INTO SCIENCE- ORIENTED CAREERS. AS A CATALYST FOR DEVELOPING THE NEXT GENERATION OF PRINCIPAL INVESTIGATORS, THIS TRAINING PROGRAM WILL IMPACT DIRECTLY ON IMPROVING TREATMENT, DECREASING COSTS, AND MOST IMPORTANTLY, IMPROVING THE LIVES OF PATIENTS WITH IMMUNE DYSREGULATION, ALL OF WHICH ARE DIRECTLY RELEVANT TO PUBLIC HEALTH.

Posted 5/15/24, 12:00 AM